The prospective observational study for the efficacy and safety of patients using Ailamide combination ophthalmic suspension with concomitant prostaglandin analogs or prostaglandin analogs / b-blocker combination drug - Study for the efficacy and safety of patients using Ailamide with concomitant prostaglandin analogs or prostaglandin analogs / b-blocker combination drug

Department of Ophthalmology, The University of Tokyo0 个研究点目标入组 101 人开始时间: 2020年6月26日最近更新: 2024年4月1日

适应症

试验速览

暂无简介。

•1.Use of other IOP lowering drug or corticosteroid within past 90 days 2.History of surgical treatment for glaucoma 3.History of intraocular surgery within past 90 days 4.Treatment of a triamcinolone acetonide within past 180 days 5.Presence of any active retinal disease which may progress 6.Presence of any active ocular disease other than POAG or ocular hypertension 7.Presence of a serious systemic disease 8.Presence of corneal abnormality which is considered to preclude accurate measurement of IOP by Goldmann applanation tonometer 9.History of corneal transplantation or keratorefractive surgery 10.Decided to be inappropriate for this study by a physician in charge accurate measurement of IOP by Goldmann applanation tonometer 9.History of corneal transplantation or keratorefractive surgery 10.Decided to be inappropriate for this study by a physician in charge

发起方

Department of Ophthalmology, The University of Tokyo